Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

The roles of nucleic acid editing in adaptation of zoonotic viruses to humans.

Ratcliff J. and Simmonds P., (2023), Curr Opin Virol, 60

Combination therapy of infliximab and thiopurines, but not monotherapy with infliximab or vedolizumab, is associated with attenuated IgA and neutralisation responses to SARS-CoV-2 in inflammatory bowel disease

Wellens J. et al, (2022), Gut, 71, 1919.2 - 1922

Convalescent plasma donors show enhanced cross-reactive neutralizing antibody response to antigenic variants of SARS-CoV-2 following immunization.

Harvala H. et al, (2022), Transfusion, 62, 1347 - 1354

Comparison of CpG- and UpA-mediated restriction of RNA virus replication in mammalian and avian cells and investigation of potential ZAP-mediated shaping of host transcriptome compositions.

Odon V. et al, (2022), RNA

Recommendations for the introduction of metagenomic next-generation sequencing in clinical virology, part II: bioinformatic analysis and reporting.

de Vries JJC. et al, (2021), Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 138

Potential APOBEC-mediated RNA editing of the genomes of SARS-CoV-2 and other coronaviruses and its impact on their longer term evolution.

Ratcliff J. and Simmonds P., (2021), Virology, 556, 62 - 72

Recommendations for the introduction of metagenomic high-throughput sequencing in clinical virology, part I: Wet lab procedure.

López-Labrador FX. et al, (2020), Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 134

Impact of virus subtype and host IFNL4 genotype on large-scale RNA structure formation in the genome of hepatitis C virus

Simmonds P. et al, (2020), RNA, 26, 1541 - 1556

Within-host genomics of SARS-CoV-2

Lythgoe KA. et al, (2020)

Cost-Effectiveness Analysis of Baseline Testing for Resistance-Associated Polymorphisms to Optimize Treatment Outcome in Genotype 1 Noncirrhotic Treatment-Naïve Patients With Chronic Hepatitis C Virus.

Fawsitt CG. et al, (2020), Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 23, 180 - 190

Binomial nomenclature for virus species: a consultation.

Siddell SG. et al, (2019), Archives of virology

The circadian clock components BMAL1 and REV-ERBα regulate flavivirus replication

Zhuang X. et al, (2019), Nature Communications, 10

Interferon lambda 4 impacts the genetic diversity of hepatitis C virus

Ansari MA. et al, (2019), eLife, 8

Use of an outbred rat hepacivirus challenge model for design and evaluation of efficacy of different immunisation strategies for HCV.

Atcheson E. et al, (2019), Hepatology

Suboptimal SVR rates in African patients with atypical Genotype 1 subtypes: implications for global elimination of Hepatitis C.

Childs K. et al, (2019), J Hepatol

The First Co-Opted Endogenous Foamy Viruses and the Evolutionary History of Reptilian Foamy Viruses.

Aiewsakun P. et al, (2019), Viruses, 11

The role of ZAP and OAS3/RNAseL pathways in the attenuation of an RNA virus with elevated frequencies of CpG and UpA dinucleotides.

Odon V. et al, (2019), Nucleic Acids Res

Increase in Enterovirus D68 Infections in Young Children, United Kingdom, 2006-2016.

Kamau E. et al, (2019), Emerging infectious diseases, 25, 1200 - 1203

Changes to virus taxonomy and the International Code of Virus Classification and Nomenclature ratified by the International Committee on Taxonomy of Viruses (2019).

Walker PJ. et al, (2019), Arch Virol

A Cost-Effectiveness Analysis of Shortened Direct-Acting Antiviral Treatment in Genotype 1 Noncirrhotic Treatment-Naive Patients With Chronic Hepatitis C Virus.

Fawsitt CG. et al, (2019), Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 22, 693 - 703

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?